TOPLINE: 

Screening tools for developmental language disorder show insufficient sensitivity before age 2, while tools administered at age 2.5 demonstrate acceptable predictive performance. These findings may inform clinical guidelines and highlight the need for further age-stratified studies.

METHODOLOGY:

• Researchers conducted a narrative synthesis of studies evaluating the validity of developmental language disorder screening tools or protocols for ages below 2 to 4 years.
• Screening tools were evaluated for sensitivity and specificity for use as a standalone screener.

TAKEAWAY:

• Screening tools administered before age 2 show insufficient sensitivity for standalone screening of developmental language disorder.
• Multiple screening tools demonstrate sensitivity and specificity exceeding 70%-80% when administered at age 2.5.
• Tools used at age 3 exhibit adequate concurrent validity for detecting language disorders.
• Age 4 screening appears more suitable for diagnosis rather than early detection purposes.

IN PRACTICE:

"Nevertheless, [developmental variability] highlights the need for screening measures with both high sensitivity and specificity to effectively distinguish transient delays from persistent language disorders. The American Academy of Pediatrics recommends ongoing developmental surveillance supplemented by standardized screening tools, which can improve early identification and facilitate timely intervention," wrote the authors of the study.

SOURCE:

The study was led by Ji Hyun Park, MD, Brookdale University Hospital and Medical Center in Brooklyn, New York, and Min Cheol Chang, MD, College of Medicine, Yeungnam University in Daegu, Republic of Korea. It was published online in Frontiers in Pediatrics.

LIMITATIONS: 

Determining the optimal age for screening has been complicated by extreme variability in language development trajectories among young children. Early screening faces challenges with high rates of spontaneous improvement in initially delayed children, making it difficult to predict delay persistence. Conversely, delayed screening risks missing the optimal intervention window. Additionally, late-onset cases with no initial delay further complicate the screening timeline. 

DISCLOSURES:

This study received funding from the National Research Foundation of Korea grant funded by the Korean government (MSIT) (No. RS-2023-00219725).

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.